Us Pharma And Biotech Summit 2024: Artificial Intelligence And Machine Learning Through The Eyes Of The Fda

Tala Fakhouri, Associate Director for Policy Analysis at the FDA, discusses the use of artificial intelligence and machine learning in drug development. She highlights the FDA’s experience with over 300 submissions containing AI and machine learning components, and their role in enabling this technology. The FDA also focuses on the validity and credibility of these models in drug development.